10 Jul 2024 ADOCIA Announces that Tonghua Dongbao is Discontinuing one of the two Partnership Programs: BioChaperone® Combo Icon check
22 Jun 2024 Development of a once-a-month formulation of Semaglutide from an innovative injectable and biodegradable hydrogel, Poster, Dr Olivier Soula, 84th scientific Sessions, ADA 2024, Orlando, USA Icon check
22 Jun 2024 AdOral ®—A Versatile Platform for Improved Oral Peptide Absorption, Poster, Dr Ouardane Jouannot, 84th scientific Sessions, ADA 2024, Orlando, USA Icon check
22 Jun 2024 AdoShell®, a non fibrotic, immunoprotective encapsulation system for human islets transplantation shows promising results for clinical application as a cure for people with Type 1 Diabetes, Poster, Dr Ouardane Jouannot, 84th scientific Sessions, ADA 2024, Orlando, USA Icon check
18 Jun 2024 ADOCIA Announces Three Presentations at the American Diabetes Association 84th Scientific Sessions Icon check
17 Jun 2024 Number of Shares and Voting Rights of ADOCIA as of May 31 st, 2024 Icon check
06 Jun 2024 ADOCIA confirms its eligibility for the PEA–PME Icon check
03 Jun 2024 ADOCIA Announces Appointment of Mathieu William Gilbert as Chief Operating Officer Icon check
Interview Olivier Soula – La France de Demain, Radio Classique – May 2024 (FR)
23 May 2024 ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 13th, 2024 in Paris Icon check
15 May 2024 Number of shares and voting rights of ADOCIA as of April 30th, 2024 Icon check
14 May 2024 ADOCIA Reports First Quarter 2024 Financial Results and Provides a Business Update Icon check
Olivier Soula – LSX World Congress – April 2024
29 Apr 2024 ADOCIA Announces the Release of its Universal Registration Document for the Year 2023 Icon check
24 Apr 2024 ADOCIA Announces Full Year 2023 Financial Results and Provides a Corporate and Financial Update Icon check
12 Apr 2024 Number of shares and voting rights of ADOCIA as of March 31st, 2024 Icon check
Interview Olivier Soula – Le Journal des Biotechs – March 2024 (FR)
22 Mar 2024 AdoShell®, un nouveau biomatériau pour la transplantation d’ilots, Oral Presentation, Dr Rosy Eloy, Congrès annuel de la SFD 2024 Icon check
21 Mar 2024 ADOCIA Announces a €2 Million Fundraising from its two Main Shareholders and a Member of its Management, and the Signature of an Equity Financing Line with Vester Finance Icon check
BIO-Europe Spring 2024: Interview with Jérémy Benattar
15 Mar 2024 Number of shares and voting rights of ADOCIA as of February 29th, 2024 Icon check
06 Mar 2024 ADOCIA Announces Its Participation at Key Events Icon check
Web-conference – 4th Quarter 2023 Financial Results (FR)
27 Feb 2024 ADOCIA Reports Fourth Quarter 2023 Financial Results and Provides a Business Update Icon check
13 Feb 2024 Number of shares and voting rights of ADOCIA as of January 31st, 2024 Icon check
25 Jan 2024 ADOCIA Announces its Financial Calendar for 2024 Icon check
17 Jan 2024 ADOCIA Announces Half year report on Adocia’s liquidity agreement with Kepler Capital Markets Icon check
16 Jan 2024 Number of shares and voting rights of ADOCIA as of December 31st, 2023 Icon check
Olivier Soula – Le Revenu TV – Dec. 2023 (FR)
Web conférence – Diabète : un laboratoire pour le futur de la santé – déc. 2023 (FR)
15 Dec 2023 Number of shares and voting rights of ADOCIA as of November 30th, 2023 Icon check
23 Nov 2023 Letter to Shareholders – November 2023 Icon check
Olivier Soula – Investival Showcase
15 Nov 2023 Number of shares and voting rights of ADOCIA as of October 31st, 2023 Icon check
09 Nov 2023 ADOCIA Revealed Promising Preclinical Data on AdoShell® Islets for Cell Therapy of Diabetes Icon check
28 Oct 2023 How to deliver a therapeutic dose of encapsulated human islets? , Oral Presentation, Dr Rosy Eloy, IPITA-IXA-CTRMS Joint Congress 2023, San Diego, USA Icon check
25 Oct 2023 ADOCIA Reports Financial Results of Third Quarter 2023 and Provides an Update on its Activities Icon check
23 Oct 2023 ADOCIA’s Partner Tonghua Dongbao Announces Positive Results of Three Clinical Trials on BioChaperone® Combo Icon check
12 Oct 2023 Number of shares and voting rights of ADOCIA as of September 30th, 2023 Icon check
Jérémy Benattar – Investisseur.TV (FR)
Olivier Soula – Bourse et Valeurs, Lyon Pole Bourse (FR)
05 Oct 2023 ADO12, a new allogenic islet encapsulation device for islet transplantation without immunosuppression, Oral Presentation, Dr Anne-Lise Gaffuri, 59th annual meeting, EASD 2023, Hamburg, Germany Icon check
25 Sep 2023 ADOCIA Announces Oral Presentations on AdoShell® Islets at EASD and IPITA-IXA-CTRMS Congresses Icon check
18 Sep 2023 ADOCIA Announces First Half 2023 Financial Results and Provides a Business Update Icon check
14 Sep 2023 Number of shares and voting rights of ADOCIA as of August 31st, 2023 Icon check
Join our mailing list. Subscribe